Targeting Fanconi Anemia/Brca2 Pathway Defects in Cancer: The Significance of Preclinical Pharmacogenomic Models

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-06-1637
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Defects in the Fanconi Anemia Pathway and Chromatid Cohesion in Head and Neck Cancer

Cancer Research
Cancer ResearchOncology
2015English

Targeting the Fanconi Anemia/Brca Pathway Circumvents Drug Resistance in Multiple Myeloma

Cancer Research
Cancer ResearchOncology
2009English

Expanded Roles of the Fanconi Anemia Pathway in Preserving Genomic Stability

Genes and Development
GeneticsDevelopmental Biology
2010English

Regulated Degradation of FANCM in the Fanconi Anemia Pathway During Mitosis

Genes and Development
GeneticsDevelopmental Biology
2009English

Fanconi Anemia

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2018English

Importance of Finding the Bona Fide Target of the Fanconi Anemia Pathway

Genes and Environment
Social PsychologyGeneticsEnvironmental Science
2019English

Fanconi Anemia

Bangladesh Medical Journal Khulna
2018English

FANCJ Suppresses Microsatellite Instability and Lymphomagenesis Independent of the Fanconi Anemia Pathway

Genes and Development
GeneticsDevelopmental Biology
2015English

Regulation of DNA Cross-Link Repair by the Fanconi Anemia/Brca Pathway

Genes and Development
GeneticsDevelopmental Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy